Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 11 studies | 32% ± 14% | |
ciliated cell | 10 studies | 28% ± 12% | |
oligodendrocyte precursor cell | 10 studies | 31% ± 15% | |
glutamatergic neuron | 9 studies | 47% ± 24% | |
GABAergic neuron | 8 studies | 44% ± 21% | |
oligodendrocyte | 8 studies | 27% ± 8% | |
retinal cone cell | 7 studies | 48% ± 17% | |
basal cell | 6 studies | 33% ± 17% | |
endothelial cell | 6 studies | 29% ± 13% | |
interneuron | 6 studies | 42% ± 24% | |
retinal rod cell | 6 studies | 32% ± 14% | |
neuron | 5 studies | 30% ± 9% | |
microglial cell | 5 studies | 26% ± 7% | |
epithelial cell | 5 studies | 35% ± 15% | |
retinal pigment epithelial cell | 5 studies | 62% ± 20% | |
cardiac muscle cell | 5 studies | 41% ± 17% | |
myeloid cell | 5 studies | 29% ± 13% | |
astrocyte | 5 studies | 30% ± 8% | |
retinal ganglion cell | 4 studies | 25% ± 5% | |
club cell | 4 studies | 30% ± 16% | |
GABAergic interneuron | 3 studies | 31% ± 4% | |
granule cell | 3 studies | 25% ± 6% | |
renal alpha-intercalated cell | 3 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6699.84 | 1444 / 1445 | 98% | 54.62 | 179 / 183 |
brain | 98% | 8747.78 | 2590 / 2642 | 99% | 18.78 | 698 / 705 |
uterus | 100% | 6311.14 | 170 / 170 | 96% | 32.80 | 441 / 459 |
bladder | 100% | 8710.00 | 21 / 21 | 94% | 28.15 | 472 / 504 |
adrenal gland | 100% | 4962.47 | 258 / 258 | 93% | 16.59 | 214 / 230 |
breast | 96% | 3452.98 | 442 / 459 | 96% | 27.85 | 1076 / 1118 |
skin | 95% | 3418.28 | 1716 / 1809 | 97% | 18.38 | 459 / 472 |
prostate | 99% | 7095.88 | 243 / 245 | 92% | 12.68 | 463 / 502 |
ovary | 100% | 5671.42 | 180 / 180 | 88% | 12.29 | 377 / 430 |
lung | 94% | 4019.76 | 544 / 578 | 93% | 53.91 | 1074 / 1155 |
kidney | 100% | 7702.38 | 89 / 89 | 85% | 12.44 | 770 / 901 |
intestine | 99% | 5771.16 | 961 / 966 | 86% | 8.87 | 451 / 527 |
stomach | 100% | 9324.02 | 359 / 359 | 85% | 9.66 | 242 / 286 |
pancreas | 68% | 1405.92 | 223 / 328 | 96% | 13.23 | 170 / 178 |
thymus | 97% | 3627.14 | 634 / 653 | 26% | 3.36 | 159 / 605 |
muscle | 100% | 19187.04 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9494.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 63.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.49 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 25.63 | 79 / 80 |
heart | 97% | 7165.26 | 831 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 3606.23 | 1277 / 1335 | 0% | 0 | 0 / 0 |
adipose | 95% | 3758.95 | 1146 / 1204 | 0% | 0 | 0 / 0 |
liver | 32% | 594.72 | 73 / 226 | 35% | 3.03 | 141 / 406 |
peripheral blood | 54% | 1142.82 | 498 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 3.56 | 14 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0006855 | Biological process | xenobiotic transmembrane transport |
GO_0034775 | Biological process | glutathione transmembrane transport |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0140115 | Biological process | export across plasma membrane |
GO_0070730 | Biological process | cAMP transport |
GO_0042908 | Biological process | xenobiotic transport |
GO_0098838 | Biological process | folate transmembrane transport |
GO_0035351 | Biological process | heme transmembrane transport |
GO_0015865 | Biological process | purine nucleotide transport |
GO_0030213 | Biological process | hyaluronan biosynthetic process |
GO_0070731 | Biological process | cGMP transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005796 | Cellular component | Golgi lumen |
GO_0010008 | Cellular component | endosome membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0015232 | Molecular function | heme transmembrane transporter activity |
GO_0008514 | Molecular function | organic anion transmembrane transporter activity |
GO_0015562 | Molecular function | efflux transmembrane transporter activity |
GO_0043225 | Molecular function | ATPase-coupled inorganic anion transmembrane transporter activity |
GO_0008559 | Molecular function | ABC-type xenobiotic transporter activity |
GO_0015216 | Molecular function | purine nucleotide transmembrane transporter activity |
GO_0022884 | Molecular function | macromolecule transmembrane transporter activity |
GO_0042910 | Molecular function | xenobiotic transmembrane transporter activity |
GO_0034634 | Molecular function | glutathione transmembrane transporter activity |
GO_0005524 | Molecular function | ATP binding |
GO_0042626 | Molecular function | ATPase-coupled transmembrane transporter activity |
GO_1901505 | Molecular function | carbohydrate derivative transmembrane transporter activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | ABCC5 |
Protein name | ATP binding cassette subfamily C member 5 ABCC5 protein (ATP binding cassette subfamily C member 5) ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) |
Synonyms | MRP5 |
Description | FUNCTION: ATP-dependent transporter of the ATP-binding cassette (ABC) family that actively extrudes physiological compounds, and xenobiotics from cells. Mediates ATP-dependent transport of endogenous metabolites such as cAMP and cGMP, folic acid and N-lactoyl-amino acids (in vitro) . Acts also as a general glutamate conjugate and analog transporter that can limit the brain levels of endogenous metabolites, drugs, and toxins . Confers resistance to the antiviral agent PMEA . Able to transport several anticancer drugs including methotrexate, and nucleotide analogs in vitro, however it does with low affinity, thus the exact role of ABCC5 in mediating resistance still needs to be elucidated . Acts as a heme transporter required for the translocation of cytosolic heme to the secretory pathway . May play a role in energy metabolism by regulating the glucagon-like peptide 1 (GLP-1) secretion from enteroendocrine cells (By similarity). . |
Accessions | ENST00000427120.6 A5PKY6 ENST00000437205.5 ENST00000446941.2 F8WCY8 ENST00000443497.1 ENST00000438979.6 H7C271 ENST00000265586.10 [O15440-5] O15440 ENST00000334444.11 [O15440-1] ENST00000382494.6 [O15440-4] ENST00000443376.5 [O15440-3] C9JZL5 ENST00000437341.5 F8WDH3 ENST00000392579.6 [O15440-2] E9PET4 |